about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceDiagnosis & treatment of tuberculosis in HIV co-infected patients.Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections studyTreatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, ThailandHIV and Tuberculosis: a Deadly Human SyndemicExtensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.HIV/TB co-infection in mainland China: a meta-analysisTB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasoneAntiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?Tuberculosis and pneumonia in HIV-infected children: an overviewHighly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.Diagnostic Outcomes After Chest Radiograph Interpretation in Patients With Suspected Tuberculosis and Negative Sputum Smears in a High-Burden Human Immunodeficiency Virus and Tuberculosis Setting.Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland.Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.CD4 and CD8 T-cell responses to mycobacterial antigens in African childrenTuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia.Two commentaries on 'Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children'Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.Low nutrient intake among adult women and patients with severe tuberculosis disease in Uganda: a cross-sectional study.Video Q&A: rapid urine LAM test for HIV-associated TB--potential to reduce deaths? An interview with Stephen LawnModeling tuberculosis in nonhuman primates.Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.Clinico-epidemiological profile of HIV/TB coinfected patients in Vadodara, Gujarat.Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis.Modelling challenges in context: lessons from malaria, HIV, and tuberculosisRisk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.Tuberculosis retreatment 'others' in comparison with classical retreatment cases; a retrospective cohort review.Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation.Frequent detection of anti-tubercular-glycolipid-IgG and -IgA antibodies in healthcare workers with latent tuberculosis infection in the PhilippinesA novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.Pyrido[1,2-a]benzimidazole-based agents active against tuberculosis (TB), multidrug-resistant (MDR) TB and extensively drug-resistant (XDR) TBHome-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban TanzaniaAnalysis of HLA association among North Indian HIV-positive individuals co-infected with Mycobacterium tuberculosis.
P2860
Q22241307-239A91FA-A1B2-49E5-AB8E-1FC20908A85BQ26991633-732CC4CE-81B7-4214-AE8A-3007B40B1583Q28480516-AD1C3FE6-6F22-49E4-82CA-C40205174052Q30051056-8902A47F-76B3-48AC-9D7E-242F379232F3Q30052157-324D673F-322C-4777-8F42-6336D0483737Q30433414-59F08692-C5E9-4346-8234-9BAA6E2530CDQ33588582-9A51FC14-8C2E-44E7-B3F1-25D0B2D7113DQ33732480-33BB111A-E39A-41F4-A4EE-F4A0A66E3D88Q33795967-BA1C5037-C4E9-48B9-8240-4F4E7FD614D8Q33801297-A1F7F931-A525-4A2F-80CD-7E75896DC584Q33825708-2ABC107E-3392-4650-B7BD-DDFC0B404C6BQ33901455-4BC513CA-273A-47D2-9596-F0D0AEFE4FDFQ33909457-2DD521BB-229F-4B69-BF3A-C8E75BCFD131Q33920318-9FB35B9F-BC46-4999-8167-265E10B68740Q33988111-18867F97-5D44-40A1-8843-DB914DB8213DQ33997536-3DFB0676-C633-42C8-B89A-7B9598D9BB27Q34247819-C2FC454B-729C-464D-B17B-35C28D8305C1Q34318819-15732D78-B1FB-480E-AB15-F913E869A983Q34322143-71A450E7-E3C0-44BB-9792-020B5D4D274BQ34455442-64DB5677-12DF-40E4-B5E2-747AB093B036Q34499835-44A886DB-D751-4305-9582-0BF22956C41AQ34502970-0985455D-A3ED-41F9-85C0-EFF3F54B9894Q34798215-9398E0CB-5737-4D49-BD63-3271198412D5Q34930509-A46FB519-34B3-4F76-B489-E74E2A224647Q35069594-ACB88AC1-3D22-4ECA-9E20-2A28F77E2130Q35199479-09934EF3-F974-491E-BA20-9BD88C0D4458Q35336481-8BA7EE46-2B94-4939-A368-BE8DF7D89863Q35336540-87D85208-AC2E-44C9-9583-3652A7CD457FQ35634830-8849D7EE-12E6-4765-A5D5-4173F42C85CFQ35671092-B16480AE-FCCF-4AD5-A367-8298CF4BE1C6Q35738013-93ECBA1E-B2D0-4163-9F20-28FF96460368Q35750657-3AB40A2B-95F5-4469-A49A-04412E9FDE2BQ35761800-AD4A8316-F16E-4506-8988-FA7DA6D071C2Q35851673-BF7D09B1-B412-431D-99C6-94137B9E0141Q35896541-4791D658-60E0-4181-9207-C7A03BD28EABQ35940744-2FF7CA5F-AF96-474E-B3B1-467ACF4A25B1Q36070976-1A40DCA5-088B-4643-90FC-E995EE770C2AQ36073140-3C5C6E02-A526-42C4-B062-2D64D495D170Q36101115-50056A15-2DF5-4DD7-9A67-C1DF34A9B7FDQ36103431-9D15DDDB-0C0A-4936-AEE3-1D0C76C8B48E
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epidemiology of HIV-associated tuberculosis.
@ast
Epidemiology of HIV-associated tuberculosis.
@en
Epidemiology of HIV-associated tuberculosis.
@nl
type
label
Epidemiology of HIV-associated tuberculosis.
@ast
Epidemiology of HIV-associated tuberculosis.
@en
Epidemiology of HIV-associated tuberculosis.
@nl
prefLabel
Epidemiology of HIV-associated tuberculosis.
@ast
Epidemiology of HIV-associated tuberculosis.
@en
Epidemiology of HIV-associated tuberculosis.
@nl
P2860
P1476
Epidemiology of HIV-associated tuberculosis.
@en
P2093
Gavin Churchyard
P2860
P304
P356
10.1097/COH.0B013E32832C7D61
P50
P577
2009-07-01T00:00:00Z